[1] |
中华医学会皮肤性病学分会免疫学组. 中国慢性诱导性荨麻疹诊治专家共识(2023). 中华皮肤科杂志, 2023,e20220819. doi: 10.35541/cjd.20220819.
|
[2] |
McPherson S, Reese C, Wendler MC. Methodology update: Delphi studies[J]. Nurs Res, 2018,67(5):404⁃410. doi: 10. 1097/NNR.0000000000000297.
|
[3] |
Ciałkowska M, Adamowski T, Piotrowski P, et al. What is the Delphi method? Strengths and shortcomings[J]. Psychiatr Pol, 2008,42(1):5⁃15.
|
[4] |
Zhong H, Song Z, Chen W, et al. Chronic urticaria in Chinese population: a hospital⁃based multicenter epidemiological study[J]. Allergy, 2014,69(3):359⁃364. doi: 10.1111/all.12338.
|
[5] |
Jaam M, Awaisu A, El⁃Awaisi A, et al. Use of the Delphi technique in pharmacy practice research[J]. Res Social Adm Pharm, 2022,18(1):2237⁃2248. doi: 10.1016/j.sapharm.2021.06. 028.
|
[6] |
Hutchings A, Raine R, Sanderson C, et al. A comparison of formal consensus methods used for developing clinical guidelines[J]. J Health Serv Res Policy, 2006,11(4):218⁃224. doi: 10. 1258/135581906778476553.
|
[7] |
De Bruin⁃Weller M, Biedermann T, Bissonnette R, et al. Treat⁃to⁃target in atopic dermatitis: an international consensus on a set of core decision points for systemic therapies[J]. Acta Derm Venereol, 2021,101(2):adv00402. doi: 10.2340/00015555⁃3751.
|
[8] |
Strober B, Ryan C, van de Kerkhof P, et al. Recategorization of psoriasis severity: Delphi consensus from the International Psoriasis Council[J]. J Am Acad Dermatol, 2020,82(1):117⁃122. doi: 10.1016/j.jaad.2019.08.026.
|
[9] |
Meah N, Wall D, York K, et al. The alopecia areata consensus of experts (ACE) study part II: results of an international expert opinion on diagnosis and laboratory evaluation for alopecia areata[J]. J Am Acad Dermatol, 2021,84(6):1594⁃1601. doi: 10.1016/j.jaad.2020.09.028.
|
[10] |
Richard MA, Aubin F, Beneton N, et al. Moderate psoriasis in clinical practice: french expert consensus using a modified Delphi method[J]. Adv Ther, 2022,39(11):5203⁃5215. doi: 10. 1007/s12325⁃022⁃02305⁃z.
|
[11] |
McMillan SS, King M, Tully MP. How to use the nominal group and Delphi techniques[J]. Int J Clin Pharm, 2016,38(3):655⁃662. doi: 10.1007/s11096⁃016⁃0257⁃x.
|
[12] |
Seoane J, Warnakulasuriya S, Bagán JV, et al. Assembling a consensus on actinic cheilitis: a Delphi study[J]. J Oral Pathol Med, 2021,50(10):962⁃970. doi: 10.1111/jop.13200.
|
[13] |
Schaller M, Almeida L, Bewley A, et al. Recommendations for rosacea diagnosis, classification and management: update from the global ROSacea COnsensus 2019 panel[J]. Br J Dermatol, 2020,182(5):1269⁃1276. doi: 10.1111/bjd.18420.
|
[14] |
Massey PR, Schmults CD, Li SJ, et al. Consensus⁃based recommendations on the prevention of squamous cell carcinoma in solid organ transplant recipients: a Delphi consensus statement[J]. JAMA Dermatol, 2021,157(10):1219⁃1226. doi: 10.1001/jamadermatol.2021.3180.
|
[15] |
Dhaenens B, Ferner RE, Bakker A, et al. Identifying challenges in neurofibromatosis: a modified Delphi procedure[J]. Eur J Hum Genet, 2021,29(11):1625⁃1633. doi: 10.1038/s41431⁃021⁃00892⁃z.
|
[16] |
Martinez⁃Saguer I, Dominas N, Straben U, et al. Patients with hereditary angioedema and their treatment patterns in Germany: a Delphi consensus study[J]. Eur J Dermatol, 2022,32(4):487⁃494. doi: 10.1684/ejd.2022.4272.
|
[17] |
Rick JW, De DR, Shih T, et al. Guidance on COVID⁃19 vaccination in hidradenitis suppurativa patients: a modified Delphi consensus of experts[J]. Skin Appendage Disord, 2022,8(4):287⁃290. doi: 10.1159/000521268.
|
[18] |
Takahagi S, Tanaka A, Hide M. Sweat allergy[J]. Allergol Int, 2018,67(4):435⁃441. doi: 10.1016/j.alit.2018.07.002.
|
[19] |
Altrichter S, Koch K, Church MK, et al. Atopic predisposition in cholinergic urticaria patients and its implications[J]. J Eur Acad Dermatol Venereol, 2016,30(12):2060⁃2065. doi: 10.1111/ jdv.13765.
|
[20] |
Maurer M, Metz M, Brehler R, et al. Omalizumab treatment in patients with chronic inducible urticaria: a systematic review of published evidence[J]. J Allergy Clin Immunol, 2018,141(2):638⁃649. doi: 10.1016/j.jaci.2017.06.032.
|
[21] |
Maltseva N, Borzova E, Fomina D, et al. Cold urticaria ⁃ What we know and what we do not know[J]. Allergy, 2021,76(4):1077⁃1094. doi: 10.1111/all.14674.
|
[22] |
Fukunaga A, Washio K, Hatakeyama M, et al. Cholinergic urticaria: epidemiology, physiopathology, new categorization, and management[J]. Clin Auton Res, 2018,28(1):103⁃113. doi: 10.1007/s10286⁃017⁃0418⁃6.
|
[23] |
Lawlor F, Black AK. Delayed pressure urticaria[J]. Immunol Allergy Clin North Am, 2004,24(2):247⁃258, vi⁃vii. doi: 10. 1016/j.iac.2004.01.006.
|
[24] |
Yi Q, Wang PP, He Y. Reliability analysis for continuous measurements: equivalence test for agreement[J]. Stat Med, 2008,27(15):2816⁃2825. doi: 10.1002/sim.3110.
|
[25] |
Schoonjans F, Zalata A, Depuydt CE, et al. MedCalc: a new computer program for medical statistics[J]. Comput Methods Programs Biomed, 1995,48(3):257⁃262. doi: 10.1016/0169⁃2607(95)01703⁃8.
|